Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peggy Gandia

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Clinical Pharmacokinetics|February 4, 2022
"De-Shrinking" EBEs: The Solution for Bayesian Therapeutic Drug MonitoringSarah Baklouti, Peggy Gandia, Didier Concordet
Journal of Clinical Pharmacology|February 27, 2007
Is once-daily mesalazine equivalent to the currently used twice-daily regimen? A study performed in 30 healthy volunteersPeggy Gandia, Isabelle Idier, Georges Houin
Fundamental & Clinical Pharmacology|November 30, 2005
The influence of weightlessness on pharmacokineticsPeggy Gandia, Sylvie Saivin, Georges Houin
Arzneimittel-Forschung|October 6, 2004
The perfused everted intestinal segment of rat. 1st communication: absorption kinetics of markers of different permeation mechanismsPeggy Gandia, Olivier Lacombe, John Woodley, et al.
Clinical Pharmacokinetics|July 11, 2016
Population Pharmacokinetics of Tracers: A New Tool for Medical Imaging?Peggy Gandia, Cyril Jaudet, Etienne Chatelut, et al.
Fundamental & Clinical Pharmacology|January 30, 2004
Influence of simulated weightlessness on the pharmacokinetics of acetaminophen administered by the oral route: a study in the ratPeggy Gandia, Sylvie Saivin, Michel Lavit, et al.
Presse Medicale (Paris, France : 1983)|November 26, 2019
[Assessment for antihypertensive drug intake in France in 2019 and adherence]Béatrice Bouhanick, Bernard Vaïsse, Anaïs Schavgoulidze, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 27, 2024
Vancomycin population pharmacokinetic models: Uncovering pharmacodynamic divergence amid clinicobiological resemblancePeggy Gandia, Sahira Chaiben, Nicolas Fabre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2013
Long-term prospective population PK study in GIST patients--letterEtienne Chatelut, Peggy Gandia, Verena Gotta, et al.
Clinical Pharmacokinetics|September 17, 2023
Multivariate Exact Discrepancy: A New Tool for PK/PD Model EvaluationSarah Baklouti, Emmanuelle Comets, Peggy Gandia, et al.
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Clinical Pharmacokinetics|February 4, 2022
"De-Shrinking" EBEs: The Solution for Bayesian Therapeutic Drug MonitoringSarah Baklouti, Peggy Gandia, Didier Concordet
Journal of Clinical Pharmacology|February 27, 2007
Is once-daily mesalazine equivalent to the currently used twice-daily regimen? A study performed in 30 healthy volunteersPeggy Gandia, Isabelle Idier, Georges Houin
Fundamental & Clinical Pharmacology|November 30, 2005
The influence of weightlessness on pharmacokineticsPeggy Gandia, Sylvie Saivin, Georges Houin
Arzneimittel-Forschung|October 6, 2004
The perfused everted intestinal segment of rat. 1st communication: absorption kinetics of markers of different permeation mechanismsPeggy Gandia, Olivier Lacombe, John Woodley, et al.
Clinical Pharmacokinetics|July 11, 2016
Population Pharmacokinetics of Tracers: A New Tool for Medical Imaging?Peggy Gandia, Cyril Jaudet, Etienne Chatelut, et al.
Fundamental & Clinical Pharmacology|January 30, 2004
Influence of simulated weightlessness on the pharmacokinetics of acetaminophen administered by the oral route: a study in the ratPeggy Gandia, Sylvie Saivin, Michel Lavit, et al.
Presse Medicale (Paris, France : 1983)|November 26, 2019
[Assessment for antihypertensive drug intake in France in 2019 and adherence]Béatrice Bouhanick, Bernard Vaïsse, Anaïs Schavgoulidze, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 27, 2024
Vancomycin population pharmacokinetic models: Uncovering pharmacodynamic divergence amid clinicobiological resemblancePeggy Gandia, Sahira Chaiben, Nicolas Fabre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2013
Long-term prospective population PK study in GIST patients--letterEtienne Chatelut, Peggy Gandia, Verena Gotta, et al.
Clinical Pharmacokinetics|September 17, 2023
Multivariate Exact Discrepancy: A New Tool for PK/PD Model EvaluationSarah Baklouti, Emmanuelle Comets, Peggy Gandia, et al.
Pageof 10